Skip to content
AusGrant
Federal Forecasted GRANTS-GOV-359866

Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)

National Institutes of Health (NIH) · Competitive · Science & Technology

At a glance

Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe) is a federal competitive grant from National Institutes of Health for the science & technology sector. Eligible applicants: Public housing authorities/Indian housing authorities; Independent school districts; Private institutions of higher education; Small businesses; Nonprofits having a 501(c)(3) status with the IRS, other than institutions. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.

Amount
See listing
Deadline
Rolling
Type
Competitive
Status
Forecasted

About this program

The National Center for Advancing Translational Science (NCATS) seeks to advance its mission by advancing research on extracellular vesicles (EVs) and their use as therapeutics in the field of regenerative medicine.The main objective of this program, Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe), is to support the translation of EV-based therapeutics in regenerative medicine. EVs, like exosomes and microvesicles, are crucial mediators of intercellular communication, carrying diverse cargo like proteins, nucleic acids, and lipids. In regenerative medicine, EVs play a significant role by influencing cellular behaviors during tissue repair and regeneration. Due to their natural function in intercellular communication, EVs represent a novel, cell-free, therapeutic tool. EVs can be further engineered to deliver therapeutic agents or modulate signaling pathways involved in repair/regeneration.Areas of interest for ExTReMe could include, but are not limited to:direct EV therapy (stem cell-isolated EVs produced under GLP conditions, and stored as off-the-shelf therapies);designer EVs (personalized to the individual patient’s needs).Grant authorities that allow the National Center for Advancing Translational Science (NCATS) to forecast this opportunity are as follows: 42 U.S. Code § 287a - Cures Acceleration Network

Who can apply

Public housing authorities/Indian housing authorities; Independent school districts; Private institutions of higher education; Small businesses; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); State governments; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; County governments; Public and State controlled institutions of higher education

How to apply

Apply through Grants.gov using funding opportunity number FOR-TR-27-002. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source